Stock Scorecard
Stock Summary for Poseida Therapeutics Inc (PSTX) - $9.50 as of 5/3/2025 8:27:45 AM EST
Total Score
9 out of 30
Safety Score
23 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PSTX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PSTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PSTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PSTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for PSTX (23 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for PSTX
Financial Details for PSTX
Company Overview |
|
|---|---|
| Ticker | PSTX |
| Company Name | Poseida Therapeutics Inc |
| Country | N/A |
| Description | Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with high unmet medical needs. The company is headquartered in San Diego, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 9.50 |
| Price 4 Years Ago | 6.81 |
| Last Day Price Updated | 5/3/2025 8:27:45 AM EST |
| Last Day Volume | 2,881,069 |
| Average Daily Volume | 2,946,130 |
| 52-Week High | 9.67 |
| 52-Week Low | 1.87 |
| Last Price to 52 Week Low | 408.02% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 42.07 |
| Sector PE | 37.03 |
| 5-Year Average PE | -7.91 |
| Free Cash Flow Ratio | 4.01 |
| Industry Free Cash Flow Ratio | 17.86 |
| Sector Free Cash Flow Ratio | 29.42 |
| Current Ratio Most Recent Quarter | 3.20 |
| Total Cash Per Share | 2.37 |
| Book Value Per Share Most Recent Quarter | 0.90 |
| Price to Book Ratio | 10.62 |
| Industry Price to Book Ratio | 9.82 |
| Sector Price to Book Ratio | 21.93 |
| Price to Sales Ratio Twelve Trailing Months | 6.14 |
| Industry Price to Sales Ratio Twelve Trailing Months | 48.24 |
| Sector Price to Sales Ratio Twelve Trailing Months | 28.34 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 97,467,000 |
| Market Capitalization | 925,936,500 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -92.81% |
| Reported EPS 12 Trailing Months | -0.63 |
| Reported EPS Past Year | -0.36 |
| Reported EPS Prior Year | -1.39 |
| Net Income Twelve Trailing Months | -60,729,000 |
| Net Income Past Year | -123,400,000 |
| Net Income Prior Year | -64,000,000 |
| Quarterly Revenue Growth YOY | 667.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | 27.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 230,900,000 |
| Total Cash Past Year | 212,200,000 |
| Total Cash Prior Year | 282,500,000 |
| Net Cash Position Most Recent Quarter | 171,992,000 |
| Net Cash Position Past Year | 153,610,000 |
| Long Term Debt Past Year | 58,590,000 |
| Long Term Debt Prior Year | 58,250,000 |
| Total Debt Most Recent Quarter | 58,908,000 |
| Equity to Debt Ratio Past Year | 0.64 |
| Equity to Debt Ratio Most Recent Quarter | 0.60 |
| Total Stockholder Equity Past Year | 103,701,000 |
| Total Stockholder Equity Prior Year | 187,595,000 |
| Total Stockholder Equity Most Recent Quarter | 87,211,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -17,159,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.18 |
| Free Cash Flow Past Year | -95,266,000 |
| Free Cash Flow Prior Year | -30,696,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.68 |
| MACD Signal | 0.89 |
| 20-Day Bollinger Lower Band | -1.28 |
| 20-Day Bollinger Middle Band | 5.10 |
| 20-Day Bollinger Upper Band | 11.48 |
| Beta | 0.54 |
| RSI | 75.94 |
| 50-Day SMA | 3.57 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 4.62 |
System |
|
| Modified | 5/3/2025 8:27:45 AM EST |